Search hospitals > Alberta > CALGARY
Alberta Children's Hospital
Claim this profileCALGARY, Alberta T3B 6A8
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Brain Tumor
Conducts research for Lymphoid Leukemia
308 reported clinical trials
20 medical researchers
Summary
Alberta Children's Hospital is a medical facility located in CALGARY, Alberta. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Brain Tumor, Lymphoid Leukemia and other specialties. Alberta Children's Hospital is involved with conducting 308 clinical trials across 497 conditions. There are 20 research doctors associated with this hospital, such as Victor Lewis, MD, Aneal Khan, Lucie Lafay-Cousin, MD, and Jean Mah, MD.Area of expertise
1Leukemia
Global LeaderStage II
Stage IV
Stage III
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Victor Lewis, MDAlberta Children's Hospital4 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
27 reported clinical trials
77 drugs studied
Aneal KhanMAGIC Clinic3 years of reported clinical research
Studies Phenylketonuria
Studies Fabry Disease
10 reported clinical trials
11 drugs studied
Lucie Lafay-Cousin, MDAlberta Children's Hospital6 years of reported clinical research
Studies Brain Tumor
Studies Medulloblastoma
6 reported clinical trials
10 drugs studied
Jean Mah, MDAlberta's Children Hospital8 years of reported clinical research
Studies Duchenne Muscular Dystrophy
Studies Muscular Dystrophy
3 reported clinical trials
4 drugs studied
Clinical Trials running at Alberta Children's Hospital
Acute Myeloid Leukemia
Ovarian Tumors
Germ Cell Tumors
Leukemia
Myelodysplastic Syndrome
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Obesity
Ovarian Carcinoma
Testicular Carcinoma
Venetoclax + Chemotherapy
for Acute Myeloid Leukemia
This trial is testing whether adding venetoclax to standard chemotherapy can help young patients with relapsed AML. Venetoclax works by blocking a protein that helps cancer cells survive, making it easier for the chemotherapy to kill them. The study aims to find better treatment options for these patients who have limited choices. Venetoclax has been shown to improve overall survival in older and unfit patients with newly diagnosed acute myeloid leukemia when combined with lower intensity therapies.
Recruiting2 awards Phase 34 criteria
Stem Cell Transplantation
for Leukemia
This phase III trial compares hematopoietic (stem) cell transplantation (HCT) using mismatched related donors (haploidentical \[haplo\]) versus matched unrelated donors (MUD) in treating children, adolescents, and young adults with acute leukemia or myelodysplastic syndrome (MDS). HCT is considered standard of care treatment for patients with high-risk acute leukemia and MDS. In HCT, patients are given very high doses of chemotherapy and/or radiation therapy, which is intended to kill cancer cells that may be resistant to more standard doses of chemotherapy; unfortunately, this also destroys the normal cells in the bone marrow, including stem cells. After the treatment, patients must have a healthy supply of stem cells reintroduced or transplanted. The transplanted cells then reestablish the blood cell production process in the bone marrow. The healthy stem cells may come from the blood or bone marrow of a related or unrelated donor. If patients do not have a matched related donor, doctors do not know what the next best donor choice is. This trial may help researchers understand whether a haplo related donor or a MUD HCT for children with acute leukemia or MDS is better or if there is no difference at all.
Recruiting2 awards Phase 3
Diagnostic Testing
for Pediatric Leukemia
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.
Recruiting1 award Phase 1 & 211 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Alberta Children's Hospital?
Alberta Children's Hospital is a medical facility located in CALGARY, Alberta. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Brain Tumor, Lymphoid Leukemia and other specialties. Alberta Children's Hospital is involved with conducting 308 clinical trials across 497 conditions. There are 20 research doctors associated with this hospital, such as Victor Lewis, MD, Aneal Khan, Lucie Lafay-Cousin, MD, and Jean Mah, MD.